On November 27, 2023, all drug manufacturers must participate in an electronic package-level traceability system, commonly known as the “interoperability” requirement.
EVERSANA is equipped to help manufacturers navigate this new guidelines and apply best practices. Let’s work together to make sure that you stay in compliance with the FDA and meet the demands of your customers throughout the supply chain.
Please fill the form to watch the webinar, “Best Practices for Compliance and Supply Chain Integration”